| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pubmed | Evolution of the regulators of G-protein signaling multigene family in mouse and human. | 7.54e-05 | 51 | 9 | 2 | 11829488 | |
| Pubmed | Arid1b haploinsufficiency disrupts cortical interneuron development and mouse behavior. | 9.10e-05 | 56 | 9 | 2 | 29184203 | |
| Pubmed | Analysis of BCL6-interacting proteins by tandem mass spectrometry. | 1.12e-04 | 62 | 9 | 2 | 16147992 | |
| Pubmed | 1.91e-04 | 81 | 9 | 2 | 16110338 | ||
| Interaction | DCDC2B interactions | 4.08e-05 | 22 | 9 | 2 | int:DCDC2B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 3.64e-03 | 473 | 9 | 2 | chr17q21 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-06 | 183 | 9 | 3 | 2f0ee40e69ad1259e56e8ee4b352736900eb8901 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 189 | 9 | 3 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 189 | 9 | 3 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-06 | 189 | 9 | 3 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.71e-06 | 196 | 9 | 3 | f40d10ea7714067585493fdc89744714aa427de8 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.13e-04 | 134 | 9 | 2 | 2647453f44b0e0a8f27ef9bba750e99eb40efc8b | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 160 | 9 | 2 | c1d03c0ac9c12615a06499209fcdf18e9b6f1fba | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.45e-04 | 160 | 9 | 2 | 41d6c811c445c0ba9b6a2deb10a3b6b793172582 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-04 | 162 | 9 | 2 | 36ddebe3bb172c992739353b7b049b2dde98b559 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-3|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.68e-04 | 164 | 9 | 2 | 201aee6387e69f918d87fa87d9b5b2ab3b305f61 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.14e-04 | 172 | 9 | 2 | 490745024730df6357f6c2b81d7a64e21557c0d5 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-04 | 172 | 9 | 2 | f92a53ad2e464cd68ba1714bcc1d5911479cdf1c | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.14e-04 | 172 | 9 | 2 | a03f30a996a9474ad4cccd209476423a042df002 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-04 | 173 | 9 | 2 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.26e-04 | 174 | 9 | 2 | 53c2c132566a7682f3268c7f9138700f09c3b94d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.26e-04 | 174 | 9 | 2 | 321c6cae614d28feeee266eeb3499f2053ab79e0 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 5.26e-04 | 174 | 9 | 2 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-04 | 178 | 9 | 2 | 43eda32af2e5e28a92421612d0a4c21e5427a772 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-04 | 178 | 9 | 2 | 888add8935ef3aef9b6693c5698e9d1842e66337 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-04 | 179 | 9 | 2 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-04 | 180 | 9 | 2 | 0677bf4a5177d9cbc6716195bd966eeae8de2f31 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 181 | 9 | 2 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.81e-04 | 183 | 9 | 2 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 184 | 9 | 2 | 8c23945bafe8926f25836bc208115edd5214a2b0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.88e-04 | 184 | 9 | 2 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.88e-04 | 184 | 9 | 2 | 22c18964818fc9c8f18051f836d718937b0d8d12 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.88e-04 | 184 | 9 | 2 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 5.94e-04 | 185 | 9 | 2 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-04 | 187 | 9 | 2 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.07e-04 | 187 | 9 | 2 | 401be371b32066db926de3415bb4ce9465749dc3 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 6.13e-04 | 188 | 9 | 2 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-04 | 188 | 9 | 2 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-04 | 188 | 9 | 2 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-04 | 188 | 9 | 2 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 6.13e-04 | 188 | 9 | 2 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-04 | 189 | 9 | 2 | 55420853f730b433ef58ac9337ac84ac78a247a0 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 6.20e-04 | 189 | 9 | 2 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-04 | 189 | 9 | 2 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 6.20e-04 | 189 | 9 | 2 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 6.20e-04 | 189 | 9 | 2 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-04 | 189 | 9 | 2 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.20e-04 | 189 | 9 | 2 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.26e-04 | 190 | 9 | 2 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-04 | 190 | 9 | 2 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-04 | 190 | 9 | 2 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 6.26e-04 | 190 | 9 | 2 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.26e-04 | 190 | 9 | 2 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 6.33e-04 | 191 | 9 | 2 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-04 | 191 | 9 | 2 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-04 | 192 | 9 | 2 | 8769b67d1cad1be65da3938f916e5bf88f88f6b8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.39e-04 | 192 | 9 | 2 | 32e4a180037e516c5cc798cd9dada9385e0f43ae | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 6.53e-04 | 194 | 9 | 2 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-04 | 195 | 9 | 2 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.59e-04 | 195 | 9 | 2 | 3123e02d2894c83962ba402085b5e6422ebf8c73 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-04 | 196 | 9 | 2 | e02301642243df483fd066d978317c113c04692b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-04 | 196 | 9 | 2 | b8350340d86e4524e9616a427e7f2e116a6fb3be | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-04 | 196 | 9 | 2 | 1bfc3c85ce9501f52a912e53cbded7de74572b9d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.73e-04 | 197 | 9 | 2 | 4ea3f57cd88b8a6bb7cb4b9e3545c0fa8f331886 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-04 | 198 | 9 | 2 | 688b0eb5534dde40b8630ab8a3252c816711e02e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-04 | 198 | 9 | 2 | 4448d13511485a44fe7b549e4b8b6ad7637db624 | |
| ToppCell | Kidney-Tubules|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 6.93e-04 | 200 | 9 | 2 | 0726456906e078244a9cff35aee8c5bce4566fb1 | |
| Drug | Thiamine hydrochloride [67-03-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 4.85e-05 | 193 | 9 | 3 | 2894_DN | |
| Drug | benz(a)anthracene | 9.15e-04 | 1251 | 9 | 4 | ctd:C030935 | |
| Drug | zaprinast | 1.33e-03 | 141 | 9 | 2 | CID000005722 | |
| Drug | AC1N9ZZC | 1.49e-03 | 149 | 9 | 2 | CID004369374 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.73e-03 | 161 | 9 | 2 | 4768_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.77e-03 | 163 | 9 | 2 | 5594_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.82e-03 | 165 | 9 | 2 | 6085_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.84e-03 | 166 | 9 | 2 | 7324_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.86e-03 | 167 | 9 | 2 | 3979_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.91e-03 | 169 | 9 | 2 | 5572_DN | |
| Drug | 15d-PGJ2; Up 200; 10uM; MCF7; HT_HG-U133A | 1.91e-03 | 169 | 9 | 2 | 6948_UP | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.93e-03 | 170 | 9 | 2 | 7043_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.93e-03 | 170 | 9 | 2 | 5260_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.93e-03 | 170 | 9 | 2 | 4153_DN | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.95e-03 | 171 | 9 | 2 | 991_UP | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.97e-03 | 172 | 9 | 2 | 6439_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.97e-03 | 172 | 9 | 2 | 4112_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.97e-03 | 172 | 9 | 2 | 2330_DN | |
| Drug | HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.02e-03 | 174 | 9 | 2 | 909_DN | |
| Drug | Tetrandrine [518-34-3]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 2.06e-03 | 176 | 9 | 2 | 7178_UP | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.06e-03 | 176 | 9 | 2 | 6546_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.09e-03 | 177 | 9 | 2 | 6434_DN | |
| Drug | Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.09e-03 | 177 | 9 | 2 | 4164_UP | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.09e-03 | 177 | 9 | 2 | 6551_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.11e-03 | 178 | 9 | 2 | 4710_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.13e-03 | 179 | 9 | 2 | 5086_UP | |
| Drug | Mitoxantrone dihydrochloride [70476-82-3]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.23e-03 | 183 | 9 | 2 | 3232_DN | |
| Drug | Helveticoside [630-64-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.25e-03 | 184 | 9 | 2 | 3945_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.25e-03 | 184 | 9 | 2 | 1835_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.25e-03 | 184 | 9 | 2 | 3643_UP | |
| Drug | Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.28e-03 | 185 | 9 | 2 | 6243_UP | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; PC3; HT_HG-U133A | 2.33e-03 | 187 | 9 | 2 | 5116_UP | |
| Drug | trichostatin A; Down 200; 0.1uM; PC3; HG-U133A | 2.33e-03 | 187 | 9 | 2 | 448_DN | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 2.37e-03 | 189 | 9 | 2 | 6954_UP | |
| Drug | Azlocillin sodium salt [37091-65-9]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 2.40e-03 | 190 | 9 | 2 | 3468_UP | |
| Drug | Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; PC3; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 4580_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 6776_UP | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 5917_UP | |
| Drug | Beta-Escin [11072-93-8]; Up 200; 3.2uM; PC3; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 3807_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 6958_UP | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 1661_DN | |
| Drug | Ethacrynic acid [58-54-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 3181_DN | |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; HL60; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 2996_DN | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 1653_DN | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 6868_UP | |
| Drug | Triamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 2078_UP | |
| Drug | Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 5986_DN | |
| Drug | Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 3446_UP | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 1642_DN | |
| Drug | Doxazosin mesylate [77883-43-3]; Down 200; 7.4uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 6642_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 7001_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 2523_DN | |
| Drug | Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; HL60; HG-U133A | 2.50e-03 | 194 | 9 | 2 | 1437_DN | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 3875_DN | |
| Drug | ICI 182,780; Up 200; 1uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 1205_UP | |
| Drug | monastrol; Up 200; 100uM; MCF7; HG-U133A | 2.53e-03 | 195 | 9 | 2 | 311_UP | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; HL60; HG-U133A | 2.53e-03 | 195 | 9 | 2 | 1441_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 6999_UP | |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; HL60; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 2336_DN | |
| Drug | (-)-depudecin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 2.53e-03 | 195 | 9 | 2 | 874_UP | |
| Drug | Zalcitabine [7481-89-2]; Up 200; 19uM; HL60; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 2932_UP | |
| Drug | Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 4692_DN | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 6063_UP | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 4581_DN | |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 3478_UP | |
| Drug | Tocainide hydrochloride; Down 200; 17.4uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 7351_DN | |
| Drug | Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 6821_DN | |
| Drug | Moxonidine [75438-57-2]; Down 200; 16.6uM; HL60; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 2923_DN | |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 2775_DN | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 6950_UP | |
| Drug | Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 2784_UP | |
| Drug | Betamethasone [378-44-9]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 6728_DN | |
| Drug | Ascorbic acid [50-81-7]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 5407_UP | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 3371_UP | |
| Drug | Sulfaphenazole [526-08-9]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 1794_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 5318_UP | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 1531_DN | |
| Drug | PHA-00767505E [723337-45-9]; Down 200; 10uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 6591_DN | |
| Disease | respiratory symptom change measurement, response to placebo | 8.73e-06 | 17 | 8 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | thalamus volume | 2.27e-04 | 85 | 8 | 2 | EFO_0006935 | |
| Disease | neuroimaging measurement | 2.32e-03 | 1069 | 8 | 3 | EFO_0004346 | |
| Disease | blood urea nitrogen measurement | 6.17e-03 | 452 | 8 | 2 | EFO_0004741 | |
| Disease | PR interval | 7.35e-03 | 495 | 8 | 2 | EFO_0004462 | |
| Disease | intraocular pressure measurement | 7.76e-03 | 509 | 8 | 2 | EFO_0004695 | |
| Disease | electrocardiography | 8.39e-03 | 530 | 8 | 2 | EFO_0004327 | |
| Disease | urate measurement, bone density | 1.13e-02 | 619 | 8 | 2 | EFO_0003923, EFO_0004531 | |
| Disease | reaction time measurement | 1.27e-02 | 658 | 8 | 2 | EFO_0008393 | |
| Disease | Abnormality of refraction | 1.33e-02 | 673 | 8 | 2 | HP_0000539 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSFSRRTPNSSSYCP | 331 | Q8N9N5 | |
| LKPRDPCCPSRSFFS | 166 | Q6GMV1 | |
| SPSSPFSSSCRSPRK | 491 | O75916 | |
| FSSSCRSPRKPFASP | 496 | O75916 | |
| FSRLFSSSSSPPPAK | 576 | Q9UPT6 | |
| SSFNSPCRDSVSPPK | 541 | Q9UBK2 | |
| PTCPRTFYIPSSSKR | 371 | A8MUX0 | |
| RARSPSPCPFRSSSQ | 171 | P27987 | |
| PLSSPAASPKFCRST | 1481 | Q8IVL1 | |
| FKCPLCSRVFPSPSS | 336 | Q6ZN55 | |
| DSPSFCRPSKYSPGT | 286 | O14905 |